These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32354928)

  • 21. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
    Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
    Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
    Taylor J; McCluggage WG
    Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination.
    Nakamura E; Sato Y; Moriguchi S; Yamashita A; Higo T; Asada Y
    Case Rep Obstet Gynecol; 2015; 2015():690891. PubMed ID: 26075120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newly Categorized Seromucinous Tumor of the Ovary: Magnetic Resonance Imaging Findings.
    Han JW; Kim KA; Chang HY; Kim JW; Park YS; Lee J; Choi JW; Lee CH; Park CM
    J Comput Assist Tomogr; 2019; 43(1):119-127. PubMed ID: 30052618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seromucinous borderline tumor of the testis-A case report.
    Scholz B; Beckert M; Mordstein V; Hohmann N; Walther R; Papadopoulos T
    Hum Pathol; 2017 Feb; 60():188-191. PubMed ID: 27597522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
    Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
    J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
    Ates Ozdemir D; Usubutun A
    Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian epithelial tumors of borderline malignancy in Japan.
    Nakashima N; Nagasaka T; Oiwa N; Nara Y; Fukata S; Fukatsu T; Takeuchi J
    Gynecol Oncol; 1990 Jul; 38(1):90-8. PubMed ID: 2162318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study.
    Wu B; Li J; Tao X; Wang J; Zhu G; Lu X; Chen R
    Reprod Sci; 2023 Jun; 30(6):1927-1937. PubMed ID: 36512190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication.
    Zhang W; Tan C; Xu M; Wu X
    Eur J Surg Oncol; 2019 Nov; 45(11):2120-2125. PubMed ID: 31462390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
    Saygili U; Uslu T; Erten O; Doğan E
    Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conservative treatment of borderline ovarian tumors.
    Tazelaar HD; Bostwick DG; Ballon SC; Hendrickson MR; Kempson RL
    Obstet Gynecol; 1985 Sep; 66(3):417-22. PubMed ID: 4022501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frozen section in borderline ovarian tumors: is it reliable?
    Ureyen I; Turan T; Cirik DA; Tasci T; Boran N; Bulbul D; Tulunay G
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():115-8. PubMed ID: 25145763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucinous Ovarian Tumors.
    Mills AM; Shanes ED
    Surg Pathol Clin; 2019 Jun; 12(2):565-585. PubMed ID: 31097115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
    Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
    Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraovarian seromucinous borderline tumor: Case report and literature review.
    Sakata M; Mabuchi S; Maeda M; Nagata S; Tanaka J; Kamiura S
    J Obstet Gynaecol Res; 2024 Jul; 50(7):1263-1267. PubMed ID: 38679428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seromucinous and Mucinous Borderline Ovarian Tumors: We Need to Know More.
    Laban M; Chen X; Guo B
    Reprod Sci; 2023 May; 30(5):1684-1685. PubMed ID: 36474132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borderline mucinous cystic ovarian tumor with mural nodules (carcinosarcoma).
    Chang JS; Chua CC; Lee CC
    Ann Saudi Med; 2012; 32(4):415-20. PubMed ID: 22705615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
    Alanbay I; Aktürk E; Coksuer H; Ercan CM; Karaşahin E; Dede M; Yenen MC; Ozan H; Dilek S
    Eur J Gynaecol Oncol; 2012; 33(1):25-30. PubMed ID: 22439401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.